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euroﬁlaments possess side arms that comprise the
carboxy-terminal domains of neuroﬁlament middle
and heavy chains (NFM and NFH); that of NFH is
heavily phosphorylated in axons. Here, we demonstrate
that phosphorylation of NFH side arms is a mechanism for
regulating transport of neuroﬁlaments through axons. Mutants
in which known NFH phosphorylation sites were mutated to
preclude phosphorylation or mimic permanent phosphory-
lation display altered rates of transport in a bulk transport
N
 
assay. Similarly, application of roscovitine, an inhibitor of
 
the NFH side arm kinase Cdk5/p35, accelerates neuroﬁlament
transport. Analyses of neuroﬁlament movement in transfected
living neurons demonstrated that a mutant mimicking
permanent phosphorylation spent a higher proportion of
time pausing than one that could not be phosphorylated.
Thus, phosphorylation of NFH slows neuroﬁlament transport,
and this is due to increased pausing in neuroﬁlament
movement.
 
Introduction
 
Neurofilaments are transported through axons by a process
termed slow axonal transport. However, recent studies have
shown that they move at conventional fast rates of 
 
 
 
1 
 
 
 
m/s
but that this movement is interrupted by prolonged pauses
(Yabe et al., 1999; Prahlad et al., 2000; Roy et al., 2000;
Shah et al., 2000; Wang et al., 2000; Wang and Brown,
2001). At any one time, most neurofilaments are therefore
stationary, giving rise to an overall slow rate of transport.
The molecular mechanisms that regulate neurofilament
transport are not properly understood, but a body of evi-
dence associates increased phosphorylation of neurofilament
side arms with slower transport rates (Ackerley et al., 2000;
Sanchez et al., 2000; Yabe et al., 2001). In most mature
neurons, neurofilaments comprise three subunit proteins,
neurofilament light, middle, and heavy chains (NFL, NFM,
and NFH),* and the carboxy-terminal domains of NFM
and NFH form side arms that extend from the filament.
These NFM/NFH side arms are phosphorylated in axons,
with that of NFH being particularly heavily phosphorylated
(Pant et al., 2000). Much of this phosphate is located in a
domain that contains repeats of the motif lys-ser-pro (KSP).
Kinases that phosphorylate the serines in these KSPs include
Cdk5/p35, GSK-3
 
 
 
/
 
 
 
, and members of the MAPK/SAPK
family (Pant et al., 2000). Here, we have investigated the
role of side arm phosphorylation in neurofilament transport
by analyzing movement of EGFP-tagged phosphorylation
mutants of NFH in neurons. Our results provide direct
experimental evidence to support a role for NFH side arm
phosphorylation as a regulator of neurofilament transport.
 
Results and discussion
 
GFP–NFH coassembles with NFL and NFM, 
and phosphorylation of GFP–NFH mimics 
that of endogenous NFH in neurons
 
We confirmed that amino-terminal tagging of NFH with
GFP does not influence its ability to form neurofilaments by
studying its assembly properties in SW13
 
  
 
cells that do not
contain intermediate filaments. Transfection of GFP-tagged
wild-type NFH (GFP–NFHwt) or phosphorylation mutants
of NFH (GFP–NFHala and GFP–NFHasp) with NFL,
NFL 
 
 
 
 NFM, and NFL 
 
  
 
NFM 
 
  
 
NFH into SW13
 
 
 
cells all led to the formation of neurofilament networks that
were not noticeably different from those formed by wild-
type, untagged NFH (unpublished data; Fig. 1, A–F).
Transfected GFP–NFHwt, GFP–NFHala, and GFP–NF-
Hasp also colocalized with endogenous neurofilaments in rat
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cortical neurons (Fig. 1, G–L). These results are in agree-
ment with earlier studies of GFP–NFH/M (Ackerley et al.,
2000; Roy et al., 2000; Wang et al., 2000).
NFH and NFM side arms are heavily phosphorylated in
axons but not cell bodies. Thus, antibodies 8D8 and RT97,
which detect phosphorylated NFH/NFM side arms, and an-
tibody RMO45, which detects phosphorylated NFM side
arms, all labeled axons but not cell bodies in cortical neurons
(Fig. 1, M and N, 8D8 and RT97). Labeling of axons with
RT97 commenced 
 
 
 
20 
 
 
 
m from cell bodies, which was de-
termined by analyzing RT97 and NA1211 dual-labeled neu-
rons; NA1211 detects NFH irrespective of its phosphoryla-
tion status. These results are consistent with earlier analyses
of NFM/H phosphorylation in cortical neurons (Ackerley et
al., 2000; Brownlees et al., 2000).
Transfection of GFP–NFHwt, GFP–NFHala, or GFP–
NFHasp did not alter this RT97/8D8 labeling pattern over
the time periods in which GFP–NFH transport was investi-
gated (140–260 min and 48 h after transfection, see below);
cell bodies remained negative and axons positive for RT97/
8D8. Furthermore, regions of axons that contained GFP–
NFHwt showed increased RT97/8D8 staining, which shows
that phosphorylation of the GFP–NFH species on these
epitopes is mimicking that of endogenous NFH (unpub-
lished data; Fig. 1, O–R).
 
At least some serines within KSP repeats 44–48, 50, 
and 51 of NFH are targeted by Cdk5/p35
 
Most phosphorylation sites in NFH side arm are within a
domain that contains repeats of the motif KSP (Fig. 2 A),
but only 12 of these have been formally identified as in vivo
phosphorylation sites in the rat (Elhanany et al., 1994).
KSPs with the motif KSPXK are believed to be targeted by
Cdk5/p35, and several lines of evidence indicate that these
are functionally significant (Shetty et al., 1993; Guidato et
al., 1996; Sun et al., 1996; Bajaj and Miller, 1997). We
therefore chose to analyze the effect of Cdk5/p35 phosphor-
ylation on NFH transport. The known in vivo phospho-
serines within the consensus Cdk5/p35 motif are those in re-
peats 44–48, 50, and 51 (Elhanany et al., 1994), and these
were mutated to alanine to preclude phosphorylation or as-
partate to mimic permanent phosphorylation (Fig. 2 A).
There are many examples where the substitution of such a
charged residue accurately mimics the functional effect of
phosphorylation (Eidenmuller et al., 2000).
Transfection of NFHwt alone into COS cells revealed
that it had an accelerated rate of migration on SDS-PAGE
compared with hyperphosphorylated NFH from brain when
blots were probed with antibody NA1211 (Fig. 2 B). How-
ever, cotransfection with Cdk5/p35 induced a shift in a pro-
 
Figure 1.
 
GFP–NFH assembly and phosphorylation mimics that of 
endogenous NFH.
 
 (A–F) SW13
 
 
 
 cells transfected with NFL 
 
  
 
NFM 
 
  
 
NFH 
 
 
 
 either GFP–NFHwt (A and B), GFP–NFHala (C and D),
or GFP–NFHasp (E and F). (G–L) Cortical neurons transfected with 
GFP–NFHwt (G and H), GFP–NFHala (I and J), or GFP–NFHasp (K 
and L). GFP–NFH was detected via the GFP tag in A, C, E, G, I, and K. 
NFL was detected using antibody NR4 in B, D, F, H, J, and L. A–L 
were visualized 16 h after transfection, but similar images of cortical 
neurons were obtained at earlier (140–260 min) and later (48 h) 
times. (M and N) Cortical neurons stained with antibodies 8D8 (M) 
and RT97 (N); unstained cell bodies are arrowed. (O–R) Cortical 
neurons transfected with GFP–NFHwt and costained with RT97. 
O and P are visualized 200 min after transfection, and Q and R are 
visualized 48 h after transfection. O and Q show GFP–NFHwt via 
the GFP tag; P and R show RT97 labeling. Large arrow shows cell 
body, and small arrows show trace axon of a transfected cell. Note 
the increased RT97 labeling in regions of axons where GFP–NFHwt 
is present, but also note the absence of RT97 labeling in cell bodies. 
Bars, 20 
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portion of transfected NFHwt so that it migrated close to
NFH from brain; this shift was abolished in cells treated
with the Cdk5/p35 inhibitor roscovitine (Fig. 2 B). Simi-
larly, cotransfection of NFHwt with Cdk5/p35 increased its
reactivity with antibodies, 8D8 and RT97, that detect phos-
phorylated NFH side arms (Fig. 2 B), which is in agreement
with several previous studies (Guidato et al., 1996; Sun et
al., 1996; Bajaj and Miller, 1997).
Mutant NFH in which the Cdk5/p35 sites were mutated
to alanine (NFHala) comigrated with NFHwt when trans-
fected alone into COS cells, but mutation of the sites to as-
partate (NFHasp) induced a minor upward shift in a pro-
portion of the transfected protein. This may be due to the
aspartate residues mimicking phosphorylation that primes
phosphorylation on other residues to induce a shift. NFHala
and NFHasp did not react or reacted only weakly with anti-
bodies 8D8 and RT97. However, after cotransfection of the
mutants with Cdk5/p35, increased labeling with antibodies
8D8 and RT97 was observed; although this was significantly
weaker than NFHwt in Cdk5/p35-cotransfected cells (Fig. 2
B). Cotransfection of NFHala or NFHasp with Cdk5/p35
also induced upward mobility shifts in a proportion of the
transfected protein. However, the shift for NFHala was mi-
nor, whereas that for NFHasp was more pronounced so that
it migrated close to NFH from brain. These results are con-
sistent with the notion that some, if not all, of the sites mu-
tated in NFHala are phosphorylated by Cdk5/p35 but that
Cdk5/p35 targets other, as yet unidentified, sites.
The failure of NFHasp to react strongly with 8D8 and
RT97 is as expected. Substituting charged residues in tau
mimics the functional effects of phosphorylation but does
not generate the epitopes for phosphorylation-dependent
antibodies (Eidenmuller et al., 2000).
 
Mutation of NFH phosphorylation sites and inhibition 
of Cdk5/p35 alters NFH transport rates in a bulk 
transport assay
 
We calculated the transport rate of NFHwt, NFHala, and
NFHasp in axons using a previously described assay (Acker-
ley et al., 2000). GFP–NFHwt was transported at a rate of
 
 
 
80 
 
 
 
m/h, and this was not significantly different from
that of GFP–NFM (Fig. 3 A). These rates were linear over
the course of the experiment, which suggests that very early
movement of nonphosphorylated neurofilaments close to
cell bodies (Sanchez et al., 2000) is not being studied. In-
deed, dual labeling of GFP–NFHwt-transfected cells with
RT97 revealed that phosphorylation on NFH to generate
this epitope commences 
 
 
 
20 
 
 
 
m from the cell body (Fig. 1,
O and P). This is less than the distance travelled by GFP–
NFHwt/ala/asp at the first time point analyzed (Ackerley et
al., 2000; Fig. 3, legend).
We next examined how the mutation of phosphorylation
sites affects NFH transport. GFP–NFHasp was transported
significantly slower (52 
 
 
 
m/h) and GFP–NFHala signifi-
cantly faster (108 
 
 
 
m/h) than GFP–NFHwt (Fig. 3 B).
GFP–NFHala transport was determined for the first four
time points, because at later times, its signal became progres-
sively weaker toward the front, which precluded accurate
measurements. The weaker signal obtained from GFP–NF-
Hala at these later time points is consistent with the more
rapid transport of a finite amount of GFP–NFHala with a
concomitant dilution of fluorescent signal.
We also calculated the average distance moved by GFP–
NFHwt and GFP–NFHasp 240 min after transfection in
the presence of the Cdk5/p35 inhibitor roscovitine. Cdk5/
p35 is active in cortical neurons (Nikolic et al., 1996). 20
 
 
 
M roscovitine or vehicle was applied to the cells 130 min
after transfection and maintained throughout the course of
the experiment. Roscovitine did not induce any noticeable
changes in the cells, including alterations to nuclear mor-
phology. However, roscovitine significantly increased the
distance travelled by GFP–NFHwt at this time point but
had little effect on GFP–NFHasp (Fig. 3 C). Thus, muta-
tion of Cdk5/p35 sites in NFH to preclude or mimic per-
manent phosphorylation modulates NFH transport, and in-
hibition of Cdk5/p35 activity with roscovitine significantly
accelerates NFH transport. For all of the above assays, three
independent experiments were performed using different
preparations of plasmid DNAs.
 
Mutation of NFH phosphorylation sites alters 
NFH transport properties in transfected living 
cortical neurons
 
Although neurofilaments move at an overall slow rate of
transport, this is now known to be due to rapid movement
Figure 2. Structure and phosphorylation of rat NFH by Cdk5/p35. 
(A) Schematic of rat NFH with KSP sites underlined and mutated 
sites shown in bold. (B) Phosphorylation of NFHwt, NFHala, and 
NFHasp by Cdk5/p35 in transfected COS cells. Cells were transfected 
with NFHwt, NFHala, or NFHasp   Cdk5/p35 as indicated, and 
the samples were probed on immunoblots with antibodies NA1211, 
8D8, and RT97. RB is a sample of rat brain. 8D8 and RT97 both 
recognize phosphorylated NFH side arms; NA1211 is an NFH 
phosphorylation-independent antibody. Roscovitine (Rosc.) was 
applied 16 h before harvesting.T
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that is interrupted by prolonged pauses. This has been re-
vealed by analyses of GFP–NFM and GFP–NFH move-
ment in transfected living superior cervical ganglion (scg)
neurons (Roy et al., 2000; Wang et al., 2000). Scg neurons
possess gaps in their axonal neurofilament network
through which moving GFP–NFM/H can be visualized
several days after transfection. We found that similar gaps
in GFP–NFH fluorescence also appeared in the transfected
cortical neurons 48 h after transfection (Fig. 4, A and B).
These weaker areas of fluorescence enabled us to monitor
neurofilament movement in a manner similar to that de-
scribed for scg neurons.
To characterize GFP–NFHwt movement in cortical
neurons, we acquired time-lapse movies from 20 trans-
fected cells with the duration of observation ranging from
1.08 to 3.75 min. Moving fluorescent structures were de-
fined as those that exhibited movement 
 
 
 
0.3 
 
 
 
m in 5 s;
pauses were thus any movement less than this. The length
of GFP–NFHwt moving structures varied from 1.3 to 4.4
 
 
 
m, and movement was bidirectional. The velocity of
GFP–NFHwt movement, excluding any pauses, varied
between 0.08 and 0.96 
 
 
 
m/s in the anterograde direction
and between 0.08 and 0.93 
 
 
 
m/s in the retrograde di-
rection, but pauses in movement were observed. These
speeds and pausing characteristics are similar to those de-
scribed for GFP–NFM and GFP–NFH in scg neu-
rons (Roy et al., 2000; Wang et al., 2000). Examples of
GFP–NFHwt movement are shown in Fig. 4, A–C (see
Video 1, available at http://www.jcb.org/cgi/content/full/
jcb.200303138/DC1).
NFH side arm phosphorylation is dynamic, but the phos-
phorylation states of GFP–NFHala and GFP–NFHasp on
the seven sites investigated are defined irrespective of their
subcellular location. We therefore compared the movement
characteristics of these two mutants.
The lengths of GFP–NFHala and GFP–NFHasp moving
fluorescent structures were not noticeably different from
those of GFP–NFHwt, and their velocities, excluding
pauses, were similar to GFP–NFHwt. The two mutants also
exhibited bidirectional movement, but analyses of this re-
vealed no significant differences. Because images of moving
GFP–NFH and GFP–NFM reveal minipauses (Roy et al.,
2000; Wang et al., 2000), we next considered whether
GFP–NFHala and GFP–NFHasp displayed differences in
pausing. Moving GFP–NFHala and GFP–NFHasp spent an
average of 16 and 37% pausing, respectively, and statistical
analyses revealed a significant difference. In a separate exper-
iment, we also measured the total distances moved by GFP–
NFHala and GFP–NFHasp per minute of microscope obser-
vation time. As the majority of neurofilaments are stationary
at any one time, many movies do not show any movement.
In this assay, GFP–NFHala moved significantly more than
GFP–NFHasp. These results are summarized in Table I. Ex-
amples of GFP–NFHala and GFP–NFHasp movement and
pausing are shown in Fig. 4 C.
 
Figure 3.
 
Analyses of GFP–NFH transport in transfected neurons.
 
 
(A) Distances travelled by GFP–NFHwt and GFP–NFM at 140–260 
min after transfection. One-way ANOVA tests showed no significant 
differences between GFP–NFHwt and GFP–NFM transport at any 
time point. (B) Distances travelled by GFP–NFHwt, GFP–NFHala, 
and GFP–NFHasp at 140–260 min after transfection. One-way 
ANOVA tests showed significant differences between GFP–NFHwt 
and GFP–NFHala (P 
 
 
 
 0.045) and between GFP–NFHala and 
GFP–NFHasp (P 
 
 
 
 0.001) at the 160-min time point. GFP–NFHwt 
and GFP–NFHasp displayed significant differences at the 180-min 
time point (P 
 
  
 
0.005). At later time points, significant differences 
between all three GFP–NFH proteins were observed (P 
 
 
 
 0.001). 
(C) Histogram shows distance travelled by GFP–NFHwt and 
GFP–NFHasp 240 min after transfection in either 20 
 
 
 
M roscovitine 
(Roscov.) or vehicle-treated neurons. Roscovitine or vehicle was 
applied 130 min after transfection. An asterisk indicates treatments 
that display significant differences (P 
 
 
 
 0.001) compared with 
vehicle-treated GFP–NFHwt, as analyzed by One-way ANOVA 
tests. No significant difference of GFP–NFHasp transport was 
observed between vehicle- and roscovitine-treated neurons. As 
detailed previously (Ackerley et al., 2000), the distances travelled 
by GFP–NFHwt/ala/asp at the first (140 min) time point are all 
adjusted to zero, so as to facilitate comparisons between experiments, 
and do not represent the actual distances travelled from cell bodies. 
Each data set shown for A–C is from one representative experiment, 
and error bars are the SEM.T
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The role of NFH side arm phosphorylation is not prop-
erly understood, but a body of evidence suggests that it is
a mechanism for regulating neurofilament transport (de
Waegh et al., 1992; Ackerley et al., 2000; Sanchez et al.,
2000; Yabe et al., 2001). Here, we have used mutants of
NFH to investigate the role of phosphorylation in transport.
Using a bulk transport assay, we demonstrate that mutants
mimicking permanent phosphorylation are transported
slower, and that mutants that cannot be phosphorylated
move faster than wild-type NFH. In these assays, inhibition
of Cdk5/p35 activity with roscovitine also accelerates neu-
rofilament transport. In a second series of experiments, we
Figure 4. GFP–NFH movement in 
living neurons. (A and B) Stills from 
movies of GFP–NFHwt movement in 
anterograde (A) and retrograde (B) 
directions. The directions of movement 
(anterograde, right to left; retrograde, left 
to right) are due to the orientation of 
axons when the images were captured. 
Camera exposure times in seconds are 
shown. Bar is 5  m. (C) Representative 
movement characteristics of GFP–NFHwt, 
GFP–NFHala, and GFP–NFHasp as 
indicated. Each point represents the 
distance moved by the filament from 
its starting position measured along the 
axon in micrometers; exposures are 
every 5 s. Asterisks show pauses in 
movement of GFP–NFHasp.
 
Table I. 
 
Summary of movement characteristics of GFP–NFHala and GFP–NFHasp filaments in living cortical neurons
 
Velocity of moving GFP–NFHala and GFP–NFHasp 
excluding pauses
No difference between GFP–NFHala and GFP–NFHasp. GFP–NFHala varied between 
0.08 and 1.13 
 
 
 
m/s in the anterograde direction and between 0.08 and 1.27 
 
 
 
m/s in 
the retrograde direction; GFP–NFHasp varied between 0.08 and 1.1 
 
 
 
m/s in the 
anterograde direction and between 0.07 and 1.22 
 
 
 
m/s in the retrograde direction 
(analyzed by Mann-Whitney test).
Anterograde vs. retrograde movement of GFP–NFHala 
and GFP–NFHasp
No difference between GFP–NFHala and GFP–NFHasp (analyzed by chi-square test).
Pauses in movement of moving GFP–NFHala and 
GFP–NFHasp
GFP–NFHala pauses significantly less than GFP–NFHasp (16 vs. 37%; P 
 
 
 
 0.005 by 
Mann-Whitney test). 
Distance moved by GFP–NFHala and GFP–NFHasp 
per minute of microscope observation time
GFP–NFHala moves significantly more than GFP–NFHasp. GFP–NFHala moved a 
total of 8.64 
 
 
 
m/min of observation, whereas GFP–NFHasp moved 3.12 
 
 
 
m/min of 
observation (P 
 
 
 
 0.001 by Mann-Whitney test).
GFP–NFHala movement was characterized from movies acquired from 27 cells, with the duration of observation ranging from 1 to 2.83 min; GFP–NFHasp
movement was from 17 cells, with the duration of observation ranging from 1 to 2.83 min. Calculations of distance moved per minute of observation time
were made from 37 GFP–NFHala- and 26 GFP–NFHasp-transfected cells viewed for a total of 60 and 40.42 min, respectively.T
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analyzed neurofilament movement in living neurons and
demonstrate that mutation to mimic permanent phosphory-
lation significantly increases the proportion of time that
neurofilaments spend pausing. Together, these data provide
strong experimental evidence that NFH side arm phosphor-
ylation is a regulator of neurofilament transport.
Very recently, Rao et al. (2002) created mice in which the
side arm domain of NFH had been deleted by gene replace-
ment. These animals show no alteration in neurofilament
transport, which suggests that the side arm is not involved in
this process. However, other transgenic studies have sup-
ported a role for NFH in neurofilament transport; ablation
of the NFH gene accelerates neurofilament transport, and
increased NFH expression inhibits transport (Collard et al.,
1995; Marszalek et al., 1996; Zhu et al., 1998). Also, NFM
and NFH phosphorylation states are intimately related;
NFM phosphorylation is increased (including the RT97
epitope) in both NFH knockout and NFH side arm–deleted
mice (Tu et al., 1995; Zhu et al., 1998; Sanchez et al., 2000;
Rao et al., 2002). Thus, there are compensatory changes in
NFM after modulation of NFH expression in mice, and
these changes may well effect neurofilament transport.
The precise mechanisms by which phosphorylation inhib-
its neurofilament transport are not clear. One possibility is
that phosphorylation leads to a detachment of neurofila-
ments from their motors. Alternatively, phosphorylation
may influence neurofilament interactions with other axo-
plasmic components that somehow alter movement. The
identification of neurofilament motors will enable a better
understanding of this process.
 
Materials and methods
 
Plasmids
 
Expression plasmids for rat NFL, NFM, NFH, Cdk5, and p35 were previ-
ously described (Guidato et al., 1996; Ackerley et al., 2000). Amino-termi-
nal GFP-tagged rat NFH was prepared by cloning the cDNA into pEGFP-
C3 (CLONTECH Laboratories, Inc.).
Serines within KSP repeats 44–48, 50, and 51 of NFH side arm were
mutated to either alanine or aspartate using a Chameleon mutagenesis
kit (Stratagene) in three consecutive rounds. Serines in repeats 44 and 45
were mutated using oligonucleotides ATCTCTTCCTTCACAGGGGCCTT-
GGCCTTCTCAGGGGCCTTGGCCTCAGCTAGGGATTTTGCAC (ala) or
ATCTCTTCCTTCACAGGGTCCTTGGCCTTCTCAGGGTCCTTGGCCTCA-
GCTAGGGATTTTGCAC (asp). Serines in repeats 50 and 51 were mutated
using oligonucleotides CTGGTCTCTTCCTTCTCGGGGGCCTTGGCC-
TCCTCCTTGGCAGGAGCTTTGACCTGCTCAGGGGATCTGATGT (ala)
and CTGGTCTCTTCCTTCTCGGGGTCCTTGGCCTCCTCCTTGGCAGG-
ATCTTTGACCTGCTCAGGGGATCTGATGT (asp). Serines in repeats 46,
47, and 48 were mutated using oligonucleotides ATCCAGAGTCTT-
GGCCTTCTCAGGAGCCTTGGCCTCCTCCTTCATGGGGGCCTTGGCCT-
TCTCGGGGGCTTTCACCTCAGCTGGAGGCTTGAT (ala) and ATCC-
AGAGTCTTGGCCTTCTCAGGGTCCTTGGCCTCCTCCTTCATGGGGTCC-
TTGGCCTTCTCGGGGTCTTTCACCTCAGCTGGAGGCTTGAT (asp).
 
Cell culture and transfection
 
SW13
 
 
 
 cells, COS cells, and cortical neurons were grown and transfected
as previously described (Guidato et al., 1996; Ackerley et al., 2000). Ros-
covitine was obtained from Calbiochem and prepared as a 20 mM solution
in DMSO.
 
Immunoblot and immunofluorescence analyses
 
COS cells were processed for SDS-PAGE and immunoblotting, and
SW13
 
 
 
 cells and neurons were fixed and immunostained as previously
described (Ackerley et al., 2000). The primary antibodies used were
NA1211 (Affiniti), NR4 (Sigma-Aldrich), 8D8, and RT97.
 
Axonal transport of GFP–NFH/NFM
 
Bulk axonal transport of GFP–NFM and GFP–NFH was analyzed in corti-
cal neurons using a previously published method (Ackerley et al., 2000;
Brownlees et al., 2002; Utton et al., 2002). Statistical analyses were per-
formed using One-way ANOVA tests, and the rates of transport were cal-
culated using linear regression analyses.
To study GFP–NFH movement in living neurons, cortical neurons were
transfected as for the bulk transport assays and observed 48 h later using a
Carl Zeiss MicroImaging, Inc. Axiovert S100 microscope and a 100
 
 
 
 Fluar
lens. Cells grown on coverslips were viewed in normal medium using an
Open Perfusion Micro-Incubator equipped with bipolar temperature con-
troller (models PDM1–2 and TC-202; Medical Systems Corp.) that was at-
tached to the microscope stage. Cells were gassed with 5% CO
 
2
 
. Images
were captured from 1-s exposures taken every 5 s using a CCD camera
(model RTE/CCD-1300-Y/HS; Princeton Instruments). The shutter was con-
trolled using a motorized shutter controller (Lambda 10-2; Sutter Instru-
ments). Filter sets for EGFP were from Chroma Technology Corp. Images
were analyzed using Metamorph Software, and Quicktime movies were
prepared using Adobe Premiere.
Only cells that exhibited a healthy appearance were monitored, and we
did not acquire data from cells expressing high levels of GFP–NFH (as
judged by brightness of fluorescence) because this can induce pathological
changes (Roy et al., 2000). Statistical analyses of GFP–NFH movement in
living transfected neurons were performed using chi-square, One-way
ANOVA, and Mann-Whitney tests as indicated in the text.
 
Online supplemental material
 
The supplemental material (Video 1) is available at http://www.jcb.org/cgi/
content/full/jcb.200303138/DC1. Video 1 is a Quicktime movie of GFP–
NFHwt anterograde movement in a transfected cortical neuron. 1-s expo-
sures were taken every 5 s.
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